ERIN MCNAMARA: Open Payments
NPI 1467159061 · PORT ST LUCIE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,981 in 94 payments from 17 companies in 2025. Trend: 2023 $922 · 2024 $1,081 · 2025 $1,981
Food & beverage: $1,981
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $433 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $340 |
| Alkermes, Inc. | 13 | $228 |
| Corium, LLC | 11 | $166 |
| Teva Pharmaceuticals USA, Inc. | 5 | $159 |
| Janssen Pharmaceuticals, Inc | 4 | $141 |
| Neurocrine BioSciences, Inc. | 6 | $107 |
| Otsuka America Pharmaceutical, Inc. | 3 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $69 |
| E.R. Squibb & Sons, L.L.C. | 2 | $55 |
Products named: VRAYLAR, CAPLYTA, Azstarys, AUSTEDO XR, LYBALVI, SPRAVATO, REXULTI, INGREZZA.
Industry payments across FL — which companies pay providers there.
